Red Light vs Near-Infrared: Key Differences

Red light and near-infrared (NIR) light are both used in photobiomodulation therapy, and most consumer devices combine them. But they are not interchangeable. They penetrate tissue to different depths, interact with different chromophores at different efficiencies, and target fundamentally different structures in the body.

Understanding the distinction matters because choosing the wrong wavelength range for your goal is like applying sunscreen to treat a headache — the tool itself may be excellent, but it’s aimed at the wrong target.

Defining the ranges

The electromagnetic spectrum doesn’t have hard boundaries — it’s a continuum. But the conventions used in photobiomodulation research are well established:

Red light: 620–700nm Visible to the human eye. Appears as a deep red colour. The most commonly used therapeutic wavelengths within this range are 630nm, 650nm, 660nm, and 670nm.

Near-infrared (NIR): 700–1100nm Invisible to the human eye, though you may see a faint glow from NIR LEDs (your camera sensor can detect it even when your eyes cannot). The most commonly used therapeutic wavelengths are 810nm, 830nm, 850nm, and 940nm.

Both ranges fall within the first optical window of biological tissue — the region where absorption by water, oxyhaemoglobin, and deoxyhaemoglobin is low enough to allow meaningful penetration. This is not a coincidence; it is precisely why these wavelengths are therapeutically useful.

Penetration depth: the fundamental difference

The single most important distinction between red and NIR light is how deep they travel into the body.

Red light (620–700nm) penetrates approximately 1–2cm into tissue. It is readily absorbed by structures in the epidermis, dermis, and superficial subcutaneous tissue. Some red photons reach slightly deeper, but the majority of the therapeutic dose is delivered within the first centimetre.

NIR light (700–1100nm) penetrates 3–5cm or more, depending on the specific wavelength and tissue type. It passes through the skin surface with relatively little absorption and delivers its energy to deeper structures — muscle, tendons, joints, bone surfaces, and even superficial brain tissue through the skull.

The physics behind this difference involves three chromophores:

1. Melanin — Absorbs strongly in the visible range and progressively less as wavelength increases. Darker skin absorbs more red light than NIR light, which has clinical implications for dosing.

2. Haemoglobin — Both oxyhaemoglobin and deoxyhaemoglobin have absorption peaks in the visible range (particularly around 540nm and 575nm). By 700nm, haemoglobin absorption drops significantly, and by 800nm+ it reaches its minimum. This is why NIR photons can pass through blood-rich tissue more easily.

3. Water — Absorbs minimally below about 900nm, then rises sharply. This sets the upper practical boundary for deep-penetrating wavelengths — beyond 1000nm, water absorption increasingly limits penetration.

The result is that 660nm light (the most popular red wavelength) loses approximately 90% of its intensity within the first 1cm of tissue, whilst 850nm light (the most popular NIR wavelength) retains meaningful intensity at depths of 3–4cm (Kolárová et al., 1999; Esnouf et al., 2007).

Target tissues and applications

This penetration difference directly determines which conditions each wavelength range is suited to.

When to use red light (620–700nm)

Red light excels at treating structures in the skin and immediately below it:

• Skin health and anti-ageing — Collagen synthesis occurs in the dermis, approximately 1–2mm below the surface. Red light (especially 660nm and 633nm) has the strongest evidence base for stimulating fibroblast proliferation and collagen production (Wunsch & Matuschka, 2014; Barolet, 2008).

• Wound healing (surface wounds) — Cuts, abrasions, post-surgical incisions, and ulcers respond well to red light. The target cells (keratinocytes, fibroblasts, endothelial cells) are all within red light’s effective range.

• Acne — The sebaceous glands sit in the dermis. Red light at 633nm reduces inflammation and may help regulate sebum production (Kwon et al., 2013). When combined with blue light (415nm), it also targets Propionibacterium acnes bacteria.

• Hyperpigmentation and rosacea — Surface-level pigmentation and vascular conditions respond to wavelengths that are absorbed within the first few millimetres of skin.

• Hair growth — Hair follicles sit approximately 3–5mm below the scalp surface, within the effective range of red light. Multiple RCTs have demonstrated that 650–670nm increases hair density in androgenetic alopecia (Lanzafame et al., 2013).

• Oral health — Red light is effective for gum inflammation, aphthous ulcers, and other soft tissue conditions in the mouth, where the target tissue is easily accessible.

When to use NIR light (700–1100nm)

NIR light is the appropriate choice when the target tissue lies below the skin:

• Joint pain and arthritis — The synovial membrane, cartilage, and subchondral bone in joints like the knee sit 1–3cm below the surface. Multiple systematic reviews confirm that NIR light (typically 810–850nm) reduces pain and improves function in osteoarthritis (Bjordal et al., 2003).

• Muscle recovery and sports injuries — Muscle tissue sits below skin and subcutaneous fat. NIR light reaches it; red light largely does not. Leal Junior et al. (2015) showed that NIR light before exercise reduces muscle fatigue and soreness.

• Tendon and ligament injuries — Achilles tendinopathy, rotator cuff injuries, and lateral epicondylitis (tennis elbow) all involve structures 1–3cm deep. NIR wavelengths are required to deliver adequate doses to these tissues.

• Brain and cognitive function — Transcranial photobiomodulation for traumatic brain injury, depression, and cognitive enhancement uses NIR light (predominantly 810nm) because it penetrates the skull. Red light does not reach the brain in meaningful quantities (Naeser et al., 2014; Salehpour et al., 2018).

• Bone healing — Fracture repair involves stimulating osteoblasts at bone surfaces, which may be several centimetres deep. NIR at 830nm has been shown to accelerate fracture healing in animal models (Pinheiro et al., 2006).

• Deep wound healing — Whilst surface wounds respond to red light, deeper wounds (including diabetic ulcers extending into subcutaneous tissue) benefit from the addition of NIR light to reach the wound bed.

• Nerve pain and neuropathy — Peripheral nerves often lie 1–3cm below the surface. NIR light can reach these structures; Chow et al. (2009) demonstrated pain relief in chronic neck pain using 830nm laser therapy.

The same mechanism, different depth

Both red and NIR light activate the same fundamental cellular mechanism: absorption by cytochrome c oxidase (CCO) in the mitochondrial electron transport chain. CCO has absorption peaks across both the red and NIR ranges (Karu, 2010).

When CCO absorbs a photon — whether 660nm or 850nm — it triggers:

• Dissociation of inhibitory nitric oxide from the enzyme
• Increased electron transport and ATP production
• Controlled increase in reactive oxygen species (ROS)
• Activation of transcription factors (NF-κB, AP-1)
• Downstream effects on cell proliferation, migration, and anti-inflammatory signalling

The cellular response is essentially identical. The difference lies entirely in which cells receive the light. A 660nm photon that reaches a fibroblast in the dermis will produce the same intracellular effect as an 850nm photon that reaches a chondrocyte in a knee joint. The wavelength determines delivery, not mechanism.

Why most devices combine both

Virtually every reputable red light therapy panel on the market uses a combination of red (usually 660nm) and NIR (usually 850nm) LEDs. This is not a marketing gimmick — there are sound reasons:

Complementary coverage

By combining wavelengths, a single device can treat both surface and deep tissues in the same session. Someone treating knee arthritis with NIR light simultaneously benefits from red light effects on the overlying skin and subcutaneous tissue. The combination creates a more complete treatment profile.

Research supports combination

Several studies have directly compared single-wavelength versus multi-wavelength protocols. Minatel et al. (2009) found that combining 630nm and 830nm for diabetic wound healing outperformed either wavelength alone. The surface-plus-depth approach addresses healing at multiple tissue layers simultaneously.

Practical efficiency

For home users, a combination device eliminates the need to purchase separate red and NIR panels. A single 20-minute session covers both wavelength ranges.

Common LED configurations

Most panels alternate red and NIR LEDs in a checkerboard pattern, with roughly equal numbers of each. Some devices allow you to switch between red-only, NIR-only, and combined modes — a useful feature if you want to target surface or deep tissues specifically.

Common misconceptions

”NIR is stronger than red”

This is perhaps the most widespread misunderstanding. NIR penetrates deeper, but that does not make it “stronger” or “better.” For skin conditions, red light is more effective precisely because it delivers its dose to the relevant tissue layer. Using NIR alone for anti-ageing is like trying to water a garden by aiming the hose at the sky — the water exists, but it’s going past the target.

”You can’t feel NIR, so it isn’t working”

Red light is visible; NIR is not. Some people assume that if they cannot see or feel the light, nothing is happening. In reality, NIR photons are being absorbed by tissue — you simply cannot perceive them. The biological effect is measurable regardless of whether you can sense it.

”Red light is just for skin”

Whilst red light’s primary therapeutic depth is the skin and superficial tissues, it also has effects on circulating blood cells, superficial lymphatics, and neural structures close to the skin surface. It is not exclusively a cosmetic tool.

”Infrared and near-infrared are the same thing”

Infrared is a broad category spanning 700nm to 1mm. Near-infrared (700–1400nm), mid-infrared (1400–3000nm), and far-infrared (3000nm–1mm) have completely different biological effects. Far-infrared (as used in infrared saunas) heats tissue through thermal mechanisms and does not activate CCO. Near-infrared produces photobiomodulation through non-thermal, photochemical pathways. They are fundamentally different therapies despite sharing the “infrared” label.

”Higher nanometre numbers mean deeper penetration”

This holds true only up to about 950nm. Beyond that, water absorption rises sharply, and penetration depth actually decreases. The deepest-penetrating wavelengths are in the 800–870nm range, not at higher numbers. A 1060nm photon penetrates less deeply than an 850nm photon despite having a longer wavelength.

Melanin and skin tone considerations

Red light is absorbed more strongly by melanin than NIR light is. This has practical implications:

• Darker skin tones absorb a higher proportion of red photons in the epidermis, reducing the dose delivered to deeper structures. NIR light passes through melanin more readily and is less affected by skin pigmentation.

• For dark-skinned individuals, NIR wavelengths may deliver more consistent doses to sub-surface tissues. Red light is still effective for surface conditions (the absorbed photons still stimulate epidermal cells), but the dose reaching the dermis may be reduced.

• Some researchers have suggested that dose adjustments may be warranted for darker skin tones when using red light, though clinical protocols have not yet been standardised around this variable (Ash et al., 2017).

Choosing the right wavelength for your goal

Goal	Best wavelength range	Why
Anti-ageing, collagen, wrinkles	Red (660nm)	Target tissue is dermis (1–2mm deep)
Acne, rosacea	Red (633nm, 660nm)	Sebaceous glands and inflammation in dermis
Hair growth	Red (650–670nm)	Follicles sit 3–5mm below scalp surface
Wound healing (surface)	Red (630–660nm)	Granulation tissue, keratinocytes at surface
Joint pain, arthritis	NIR (810–850nm)	Joint structures 1–3cm deep
Muscle recovery	NIR (810–850nm)	Muscle tissue below subcutaneous layer
Tendon/ligament injuries	NIR (810–850nm)	Tendons typically 1–3cm below skin
Brain/cognitive	NIR (810nm)	Must penetrate skull (~7mm bone)
Deep wound healing	Red + NIR combined	Address multiple tissue depths
General wellness	Red + NIR combined	Covers surface and deep tissues

Practical recommendations

1. For skin-specific goals (anti-ageing, acne, pigmentation), prioritise a device with strong red output. NIR won’t hurt, but the red wavelengths do the heavy lifting for surface conditions.

2. For pain, joints, or muscle recovery, prioritise NIR. A red-only device will have minimal impact on structures deeper than 1–2cm.

3. For general health and multi-purpose use, choose a combination device with both 660nm and 850nm. This covers the widest range of therapeutic applications.

4. Don’t overcomplicate wavelength selection. The difference between 650nm and 670nm, or between 830nm and 850nm, is far smaller than the difference between getting the dose right and getting it wrong. Consistent use at an appropriate dose matters more than the precise wavelength.

5. If you have darker skin, NIR wavelengths will deliver more consistent subsurface doses. Red light remains effective for surface conditions regardless of skin tone.

Summary

Red light and near-infrared are complementary tools, not competitors. Red light treats what you can see and touch — skin, surface wounds, hair follicles. NIR treats what lies beneath — joints, muscles, tendons, nerves, and brain tissue. The mechanism is the same; the depth of delivery differs.

Most people benefit from using both, which is why combination devices dominate the market. But understanding the distinction helps you make informed decisions about treatment protocols, device selection, and realistic expectations for what red light therapy can achieve at any given depth.

References

• Ash C et al. (2017). Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med Sci, 32(8):1909-1918. PMID: 28900751
• Barolet D. (2008). Light-emitting diodes (LEDs) in dermatology. Semin Cutan Med Surg, 27(4):227-238. PMID: 19150294
• Bjordal JM et al. (2003). A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother, 49(2):107-116. PMID: 12775206
• Chen AC et al. (2011). Low-level laser therapy activates NF-κB via generation of reactive oxygen species. PLoS One, 6(7):e22453. PMID: 21814580
• Chow RT et al. (2009). Efficacy of low-level laser therapy in the management of neck pain. Lancet, 374(9705):1897-1908. PMID: 19913903
• Esnouf A et al. (2007). A study to determine the optimum dose of light for photodynamic therapy. Photodiagnosis Photodyn Ther, 4(2):71-76.
• Karu TI. (2010). Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life, 62(8):607-610. PMID: 20681025
• Kolárová H et al. (1999). Penetration of the laser light into the skin in vitro. Lasers Surg Med, 24(3):231-235.
• Kwon HH et al. (2013). Low-level light therapy using light-emitting diodes for the treatment of acne vulgaris. J Am Acad Dermatol, 69(1):e28-e30.
• Lanzafame RJ et al. (2013). The growth of human scalp hair mediated by visible red light laser and LED sources. Lasers Surg Med, 45(8):487-495. PMID: 24078483
• Leal Junior EC et al. (2015). Effect of phototherapy (low-level laser therapy and light-emitting diode therapy) on exercise performance and markers of exercise recovery. Lasers Med Sci, 30(2):925-939. PMID: 24249354
• Minatel DG et al. (2009). Phototherapy promotes healing of chronic diabetic leg ulcers. Photomed Laser Surg, 27(1):93-99. PMID: 19196110
• Naeser MA et al. (2014). Significant improvements in cognitive performance post-transcranial, red/near-infrared LED treatments. Photomed Laser Surg, 32(2):115-126. PMID: 24568233
• Pinheiro AL et al. (2006). Biomodulative effects of LLLT on bone regeneration. Laser Ther, 15(4):231-238.
• Salehpour F et al. (2018). Brain photobiomodulation therapy: a narrative review. Mol Neurobiol, 55(8):6601-6636. PMID: 29327206
• Wunsch A, Matuschka K. (2014). A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomed Laser Surg, 32(2):93-100. PMID: 24286286